-
公开(公告)号：KR100369618B1
公开(公告)日：2003-01-29
申请号：KR1020000029376
申请日：2000-05-30
Applicant: 한국식품연구원
IPC: A23L1/202
Abstract: 본 발명은 스프레드형 고추장 및 그 제조방법에 관한 것이다. 보다 상세하게는 고추장과 토마토 페이스트 혼합물에 유지를 첨가하여 유화시킨 후, 펙틴, 설탕 또는 올리고당 및 유자엑스분과 같은 향신료를 첨가하여 겔화시킴으로써 독특한 풍미와 물성을 부여한 스프레드형 고추장에 관한 것이다. 본 발명은 고추장에 대하여 유자 등 과실 엑스분과 토마토페이스트를 가하여 혼합한 후 45메쉬상의 체에 통과시켜 균일한 고추장 혼합물을 제조한다. 고추장 혼합물에 대하여 버터, 대두유 등 식물성 유지 및 레시틴을 첨가하여 교반함으로서 고추장 유화물을 형성시킨다. 이 유화물에 대하여 설탕 혹은 올리고당과 펙틴을 첨가하고 온도를 높혀 펙틴과 설탕이 충분히 용해되고 젤화되면 온도를 낮추고 구연산을 첨가하여 혼합물의 농도가 30 Brix 이상 되면 용기에 충진포장하여 빵과 스낵 등에 활용가치가 큰 우수한 품질의 스프레드형 고추장 제품을 제조하는데 있다.
본 발명의 스프레드형 고추장은 빵과 스낵류 분만 아니라, 여러 가지 식품에 적용할 수 있으므로 고추장의 용도를 다양화할 것으로 기대된다.-
-
公开(公告)号：KR1020140086211A
公开(公告)日：2014-07-08
申请号：KR1020120156413
申请日：2012-12-28
Applicant: 한국식품연구원
IPC: A61K31/357 , A61P29/00 , A61P3/04
Abstract: The present invention relates to a composition for treating obesity-induced inflammation, wherein the composition contains myristicin as an active ingredient. The composition of the present invention induces the expression of adiponectin and decreases the expression of IL-6 and MCP-1 which are involved in obesity-mediated inflammation reaction so that obesity-induced inflammation can be prevented and treated.
Abstract translation: 本发明涉及一种用于治疗肥胖症引起的炎症的组合物，其中组合物含有肉豆蔻酸作为活性成分。 本发明的组合物诱导脂联素的表达并降低参与肥胖介导的炎症反应的IL-6和MCP-1的表达，从而可以预防和治疗肥胖诱发的炎症。
-
公开(公告)号：KR101322937B1
公开(公告)日：2013-10-28
申请号：KR1020110147201
申请日：2011-12-30
Applicant: 한국식품연구원
IPC: A61K31/353 , A61K9/08 , A61P17/00
Abstract: 본 발명은 어랩틴(Auraptene)을 유효성분으로 함유하는 신생혈관 촉진용 약학조성물에 관한 것으로, 본 발명에 의한 신생혈관 촉진용 약학조성물은 유효성분인 어랩틴에 의해 혈관 신생을 촉진시켜 피부판 재생, 상처 및 화상치유, 인공피부이식 및 이식용 혈관 제조 등의 조직 재생에 효과적이다.
-
公开(公告)号：KR101290059B1
公开(公告)日：2013-07-26
申请号：KR1020110068563
申请日：2011-07-11
Applicant: 주식회사디엔에이링크 , 한국식품연구원
Abstract: 본 발명은 비만인 개체의 대사증후군의 발병 위험을 효율적으로 진단하기 위한 폴리뉴클레오티드, 그를 포함하는 조성물, 마이크로어레이 및 키트 및 대사증후군의 변경된 위험도를 갖는 개체를 효율적으로 확인하는 방법을 제공한다.
-
Patent Agency Ranking96.发明公开
公开(公告)号：KR1020120061017A
公开(公告)日：2012-06-12
申请号：KR1020100109052
申请日：2010-11-04
Applicant: 한국식품연구원
Abstract: PURPOSE: A pharmaceutical composition and health functional food containing thienylbutyl isothiocyanate are provided to inhibit adipocyte differentiation. CONSTITUTION: A pharmaceutical composition for preventing and treating obesity and lipid-related metabolic disorders contains 0.1-50 wt% of thienylbutyl isothiocyanate as an active ingredient. The composition is administered in 0.01-500 mg/kg. The composition is manufactured in the form of powder, granules, tablets, capsules, suspension, emulsion, syrup, oral administration, external use formulation, suppository, or sterilized injection solution. A health functional for preventing and relieving obesity and lipid-related metabolic diseases contains the thienyl butyl isothiocyanate as an active ingredient. The health functional food is manufactured in the form of capsules, tablets, granules, powder, or beverage.
Abstract translation: 目的：提供含有噻吩基丁基异硫氰酸酯的药物组合物和保健功能食品，以抑制脂肪细胞分化。 构成：用于预防和治疗肥胖症和与脂质有关的代谢紊乱的药物组合物含有0.1-50重量％的异硫氰酸噻吩基丁酯作为活性成分。 组合物以0.01-500mg / kg施用。 组合物以粉末，颗粒，片剂，胶囊，悬浮液，乳剂，糖浆，口服给药，外用制剂，栓剂或灭菌注射液的形式制造。 用于预防和减轻肥胖症和脂质相关代谢疾病的健康功能包含异硫氰酸噻吩基丁酯作为活性成分。 保健功能食品以胶囊，片剂，颗粒，粉末或饮料的形式制造。
-
公开(公告)号：KR1020120060027A
公开(公告)日：2012-06-11
申请号：KR1020100121579
申请日：2010-12-01
Applicant: 한국식품연구원
IPC: G01N33/53 , G01N33/543 , G01N33/569
Abstract: PURPOSE: A sandwich immunoassay biochip and an immunoassay using the same are provided to accurately and quickly detect pathogens. CONSTITUTION: A sandwich immunoassay biochip contains: a first protein which binds to Fc domain conjugated to a functional group of a surface-modified solid-support; a capture antibody conjugated to the first protein; a second protein which binds to Fc site of an antibody conjugated to a functional group of surface-modified polystyrene beads; and a detection antibody conjugated to the second protein. The functional groups of the solid-support and polystyrene beads are an amine group and a carboxyl group, respectively. The solid-support is a glass, polysterene, or metal. A sandwich immunoassay using the biochip comprises: a step of contacting a sample containing an antigen to the biochip; a step of specifically binding the antibody to the capture antibody; a step of binding the detection antibody to an epitope which is not conjugated with the capture antibody; and a step of detecting specific antigen-antibody binding.
Abstract translation: 目的：提供三明治免疫测定生物芯片和使用其的免疫测定以准确和快速地检测病原体。 构成：夹心免疫测定生物芯片包含：与结合表面改性固体支持物官能团的Fc结构域结合的第一种蛋白质; 与第一蛋白质缀合的捕获抗体; 结合与表面改性的聚苯乙烯珠的官能团缀合的抗体的Fc位点的第二种蛋白质; 和与第二蛋白质缀合的检测抗体。 固体支持体和聚苯乙烯珠粒的官能团分别是胺基和羧基。 固体支持物是玻璃，聚苯乙烯或金属。 使用生物芯片的夹心免疫测定法包括：使含有抗原的样品与生物芯片接触的步骤; 将抗体特异性结合到捕获抗体的步骤; 将检测抗体与未与捕获抗体结合的表位结合的步骤; 以及检测特异性抗原 - 抗体结合的步骤。
-
公开(公告)号：KR1020120023877A
公开(公告)日：2012-03-14
申请号：KR1020100086121
申请日：2010-09-02
Applicant: 한국식품연구원
CPC classification number: C07K14/47 , C12N15/63 , C12Q1/6837 , G01N33/5302 , G01N33/6857
Abstract: PURPOSE: A protein which is specifically expressed in liver tissue, WS-H10M06630, and a gene encoding the same are provided to diagnose diseases and reduce side effect of drug. CONSTITUTION: A protein specifically expressed in liver tissue, WS-H10M06630, contains an amino acid sequence of sequence number 2. A gene encoding the protein has a base of sequence number 1. A recombinant vector contains the gene encoding the protein. A transformant is prepared by transforming with the recombinant vector. A microarray for diagnosing liver-related diseases contains the gene or an antibody to WS-H10M06630 protein.
Abstract translation: 目的：提供在肝组织中特异性表达的蛋白质，WS-H10M06630及其编码基因，用于诊断疾病，降低药物的副作用。 构成：在肝组织中特异性表达的蛋白质WS-H10M06630含有序列号2的氨基酸序列。编码蛋白质的基因具有序列号1的碱基。重组载体含有编码蛋白质的基因。 通过用重组载体转化来制备转化体。 用于诊断肝脏相关疾病的微阵列包含基因或WS-H10M06630蛋白的抗体。
-
公开(公告)号：KR1020120017912A
公开(公告)日：2012-02-29
申请号：KR1020100080863
申请日：2010-08-20
Applicant: 한국식품연구원
Abstract: PURPOSE: A method for detecting a marker contained in a biological sample is provided to diagnose and treat obesity or obesity-associated diseases. CONSTITUTION: A method for detecting a marker contained in a biological sample for diagnosing obesity comprises a step of detecting the concentration of arginine, tyrosine, pipecolic acid, benzoic acid, pantothenic acid, uric acid, phenyl acetamide, serotonin, L-carnitine, decanoyl carnitine, myristoyl carnitine, hexadekenoyl carnitine, linoleyl carnitien, vacenyl carnitine, stearoyl carnitine, lysoPC(C14:0), lysoPC(C15:0), lysoPC(C16:0), lysoPC(C16:1), lysoPC(C17:0), lysoPC(C17:1), lysoPC(C18:0), lysoPC(C18:1), lysoPC(C18:2), lysoPC(C18:3), lysoPC(C19:0), lysoPC(C20:1), lysoPC(C20:4), lysoPC(C20:5), lysoPE(C18:2), lysoPE(C20:4) or PCs marker in blood or glucose, glycerol, tyrosine, valine, 7-ketodeoxy cholic acid, and betain, L-carnitine, plamitic acid, linoleic acid, oleic acid, stearic acid, lysoPC(C14:0), lysoPC(C16:0), lysoPC(C16:1), lysoPC(C18:0), lysoPC(C18:3), lysoPC(C20:4), lysoPC(C22:6), or PCs in liver tissue.
Abstract translation: 目的：提供一种用于检测生物样品中包含的标记物的方法，用于诊断和治疗肥胖或肥胖相关疾病。 构成：用于检测用于诊断肥胖的生物样品中所含的标记物的方法包括检测精氨酸，酪氨酸，哌可酸，苯甲酸，泛酸，尿酸，苯乙酰胺，5-羟色胺，L-肉毒碱，癸酰基 肉毒碱，肉豆蔻肉碱，六酰基肉碱，亚油酰肉碱，肉桂碱肉碱，硬脂酰肉碱，溶血糖（C14：0），溶血卵磷脂（C15：0），溶血卵磷脂（C16：0），溶血卵磷脂（C16： ），lysoPC（C17：1），lysoPC（C18：0），lysoPC（C18：1），lysoPC（C18：1），lysoPC（C18：2），lysoPC（C18：3） ，血液或葡萄糖，甘油，酪氨酸，缬氨酸，7-酮基脱氧胆酸和甜菜碱中的溶血卵磷脂（C20：4），溶血卵磷脂（C20：5），溶血蛋白（C18：2），溶血蛋白（C20：4） ，L-carnitine，plamitic acid，亚油酸，油酸，硬脂酸，lysoPC（C14：0），lysoPC（C16：0），lysoPC（C16：1），lysoPC（C18：0），lysoPC（C18：3 ），溶血卵磷脂（C20：4），溶血卵磷脂（C22：6）或肝组织中的PC。
-
公开(公告)号：KR1020120003778A
公开(公告)日：2012-01-11
申请号：KR1020100064563
申请日：2010-07-05
Applicant: 한국식품연구원
CPC classification number: A61K36/66 , A61K2236/33 , Y10S514/909
Abstract: PURPOSE: A composition containing Chelidonium majus var asiaticum extract is provided to activate AMPK(5'AMP-activated protein kinase) and to ensure antiobesity. CONSTITUTION: A composition for preventing and treating obesity contains 0.1-99.9 wt% of Chelidonium majus var asiaticum extract as an active ingredient. The composition is a pharmaceutical composition or food additive composition. The food composition for preventing and treating obesity contains the extract as an active ingredient. The extract is a hot water extract or ethanol extract. The composition is manufactured in the form of beverage, gum, tea, vitamin complex, pill, powder, granule, tablet, or capsule.
Abstract translation: 目的：提供含有Chelidonium majus var asiaticum提取物的组合物以激活AMPK（5'AMP-活化的蛋白激酶）并确保抗肥胖。 构成：用于预防和治疗肥胖症的组合物含有0.1-99.9wt％的Chelidonium majus var asiaticum提取物作为活性成分。 该组合物是药物组合物或食品添加剂组合物。 用于预防和治疗肥胖症的食物组合物含有提取物作为活性成分。 提取物是热水提取物或乙醇提取物。 该组合物以饮料，口香糖，茶叶，维生素复合物，丸剂，粉末，颗粒，片剂或胶囊的形式制成。
-
-
-
-
-
-
-
-
-
Search Results
109
records
(took 0.025 seconds)
